Theranos has voided two years of blood tests, faced federal probes, had its founder banned from owning or operating a lab for two years, and is being sued by one of its biggest investors.And yet, Draper Fisher Jurvetson, the first firm to put in money into the company helmed by Elizabeth Holmes, thinks that the press' attention to Theranos has been overkill.